CONTRACT AWARD NOTICE – OFFICIAL JOURNAL

Section I: Contracting Authority

I.1)

Name, Address and Contact Point(s)

I.2)

Type of contracting Authority and Main Activity or Activities

Ministry or any other national or federal authority, including their regional or local sub-divisions National or federal agency/Office Regional or local Authority Regional or local Agency/Office Body governed by public law European Institution/Agency or International Organisation

General public services Defence Public order and safety Environment Economic and financial affairs Health Housing and community amenities Social protection Recreation, culture and religion Education

Section II: Object of the Contract

II.1)

Description

II.1.1)

Title attributed to the contract by the contracting authority

Ready to Administer Products.

II.1.2(a))

Type of works contract

II.1.2(b))

Type of supplies contract

II.1.2(c))

Type of service contract

II.1.2)

Main site or location of works, place of delivery or performance

NHS Trusts within the East Midlands region of the UK and/or other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non departmental public bodies charged with the delivery of healthcare or health related services (only through the prior approval of East Midlands Pharmacy Collaborative (EMPC).

II.1.3)

This notice involves a framework agreement

II.1.4)

Short description of the contract or purchase(s)

Participating Trusts within the East Midlands currently have insufficient capacity for the aseptic production of ready to administer products to meet their expanding needs, therefore a supplier/supplier(s) are sought to supplement the current service through the provision of a high quality, cost-effective service to supply ready to administer products.

The aim of this tender is to provide a significant improvement in the supply of ready to administer products and specifically to achieve:

— Optimisation of the formulation, presentation and labelling of products to improve safe handling and reduce risks to patients and staff. Reduced stock inventory;

— Regular, managed deliveries of agreed volumes;

— Full cost transparency per unit;

— Approved product specifications to facilitate quality assurance at trust level.

Products with a Certificate of Analysis are preferred (See award criteria for full details).

II.1.5)

Common Procurement Vocabulary (CPV)

II.1.6)

Contract covered by the government procurement agreement (GPA)

II.2)

Total final value of the contract(s)

II.2.1)

Total final value of the contract(s)

Section IV: Procedure

IV.1)

Type of procedure

IV.1.1)

Type of procedure

IV.2)

Award criteria

IV.2.1)

Award criteria

IV.2.2)

An electronic auction has been used

IV.3)

Administrative information

IV.3.1)

File reference number attributed by the contracting authority

D70.D23

IV.3.2)

Previous publication(s) concerning the same contract

Other previous publications

Section V: Award of contract

Contract No:

V.1)

Date of contract award:

V.2)

Numbers of offers received:

V.3)

Name and address of economic operator to whom the contract has been awarded

V.4)

Information on value of contract

V.5)

The contract is likely to be subcontracted

Short description of the value/proportion of the contract to be subcontracted

Section VI: Complementary Information

VI.1)

Contract related to a project and/or programme financed by community funds?

VI.2)

Additional Information

The contract will run for 2 years with an option to extend for a further 2 years.

The Contracting Authority intends to use an eTendering system in this procurement exercise and reserves the right to use a reverse auction.

The most economically advantageous tender for the provision of the goods and/or services detailed in the Specification in terms of:

1. Price;

2. Qualitative criteria of:

a. Quality to include QA assessment of risk to patient, product quality, labelling, shelf-life, method of manufacture and documentation;

b. Market risk;

c. Delivery performance.

The methodology for each given product has a 3 stage approach.

Stage 1:

All offers will initially be ranked on Price. Lowest price; highest rank.

Stage 2:

A 2nd ranking will take place with Products with a Certificate of Analysis ranked higher than those with a Certificate of Conformance.

Products with a Certificate of Conformity will not be assessed for suitability at this stage.

Stage 3:

The lowest priced offer with a Certificate of Analysis (C of A) will be assessed against the qualitative award criteria.

Products with a Certificate of Conformity will not be assessed for suitability at this stage.

Where a suitable product is identified as above, the offeror will be required to submit a sample complete with label for QA/QC review.

If that product is found to be unacceptable, the next item will be identified and assessed using the same steps.

Each line item will undergo assessment until:

— An acceptable product is identified and accepted with a C of A;

— No C of A product is acceptable or available.

At this stage, steps 1, 2 and 3 will be repeated with the C of C replacing the C of A on the 2nd ranking.

Notes — Products will be assessed (quality, market risk and evidenced delivery performance of Offerors, etc.) as described in the Invitation to Tender documentation.

Where the lowest-priced offer successfully fulfils each qualitative award criteria described that offer will be awarded to the contract.

In circumstances whereby the lowest-priced offer fails to fulfil the qualitative award criteria, this offer shall be rejected and the process repeated as stated to the next qualifying bid.

The process described above shall be repeated until at least 1 Offeror is successfully appointed to the framework agreement or none of the offers are found to be acceptable against the award criteria heretofore described. For avoidance of doubt where Offerors fail to fulfil any of the qualitative award criteria, then they shall not in any circumstances be appointed to the contract.

(Full Details Available via Tender on Bravo Portal).

VI.3)

Procedures for appeal

VI.3.1)

Body responsible for appeal procedures

Body responsible for mediation procedures

VI.3.2)

Lodging of appeals

VI.3.3)

Service from which information about the lodging of appeals may be obtained

VI.4)

Dispatch date of this Notice